Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Hypha Labs (FUNI) Short-term Investments (2016 - 2022)

Hypha Labs filings provide 10 years of Short-term Investments readings, the most recent being $20700.0 for Q4 2022.

  • On a quarterly basis, Short-term Investments fell 17.66% to $20700.0 in Q4 2022 year-over-year; TTM through Dec 2022 was $20700.0, a 17.66% decrease, with the full-year FY2022 number at $25141.0, up 1.58% from a year prior.
  • Short-term Investments hit $20700.0 in Q4 2022 for Hypha Labs, down from $25141.0 in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $73675.0 in Q2 2021 to a low of $18675.0 in Q3 2020.
  • Median Short-term Investments over the past 5 years was $25647.0 (2018), compared with a mean of $30209.7.
  • The widest YoY moves for Short-term Investments: up 280.69% in 2022, down 65.88% in 2022.
  • Hypha Labs' Short-term Investments stood at $25647.0 in 2018, then changed by 0.0% to $25647.0 in 2019, then dropped by 27.18% to $18675.0 in 2020, then soared by 34.62% to $25141.0 in 2021, then dropped by 17.66% to $20700.0 in 2022.
  • The last three reported values for Short-term Investments were $20700.0 (Q4 2022), $25141.0 (Q3 2022), and $25141.0 (Q2 2022) per Business Quant data.